Associations between GLP-1 Receptor Agonists and Ischemic Optic Neuropathy, Tirzepetide vs. Dulaglutide or Semaglutide on major cardiovascular events in T2D, and more!
This episode of Diabetes Core Update reviews articles on the association between GLP-1 receptor agonists and ischemic optic neuropathy, and compares the cardiovascular event outcomes of Tirzepatide versus Dulaglutide or Semaglutide in patients with type 2 diabetes.